NEURELIS TO PRESENT ANALYSES OF STUDY DATA FROM PEDIATRIC PATIENTS WITH SEIZURE CLUSTERS AT THE CHILD NEUROLOGY SOCIETY ANNUAL MEETING
Posters to highlight assessments of treatment with immediate-use seizure medication San Diego, CA – October 15, 2026 – Neurelis, Inc., a neuroscience company focused on the development and commercialization of therapeutics for the treatment of epilepsy and neurologic disorders characterized by high unmet medical need, today announced it will present three posters at the […]